The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary
Cancer Treat Rep
.
1983 Sep;67(9):767-72.
Author
J M Venditti
PMID:
6883352
No abstract available
MeSH terms
Animals
Antineoplastic Agents / administration & dosage*
Drug Evaluation, Preclinical / methods*
Leukemia, Experimental / drug therapy*
Mice
National Institutes of Health (U.S.)
Research Design
United States
Substances
Antineoplastic Agents